Boosted protease inhibitor (PI/r) monotherapy is effective in clinical practice

被引：0
|
作者：
Simpkin, E. [1 ]
Richardson, C. [1 ]
Fisher, M. [1 ]
机构：
[1] BSUH NHS Trust, Brighton, E Sussex, England
来源：
HIV MEDICINE | 2010年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：19 / 19
页数：1
相关论文
共 50 条
  • [1] Effectiveness of monotherapy with a ritonavir-boosted protease inhibitor for HIV patients in clinical practice
    Moron Romero, Rocio
    Valle, Margarita
    Rodriguez, Alejandro
    Nieto, Pelayo
    Casas, Inmaculada
    Cabeza, Jose
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2017, 39 (01) : 330 - 330
  • [2] Effectiveness of ritonavir-boosted protease inhibitor monotherapy in routine practice
    Fonquernie, L.
    Lefebvre, B.
    Valin, N.
    Morand-Joubert, L.
    Boyd, A.
    Meynard, J.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2012, 15 : 155 - 155
  • [3] Effectiveness of Ritonavir-Boosted Protease Inhibitor Monotherapy in Clinical Practice Even with Previous Virological Failures to Protease Inhibitor-Based Regimens
    Lopez-Cortes, Luis F.
    Castano, Manuel A.
    Lopez-Ruz, Miguel A.
    Rios-Villegas, Maria J.
    Hernandez-Quero, Jose
    Merino, Dolores
    Jimenez-Aguilar, Patricia
    Marquez-Solero, Manuel
    Terron-Pernia, Alberto
    Tellez-Perez, Francisco
    Viciana, Pompeyo
    Orihuela-Canadas, Francisco
    Palacios-Baena, Zaira
    Vinuesa-Garcia, David
    Fajardo-Pico, Jose M.
    Romero-Palacios, Alberto
    Ojeda-Burgos, Guillermo
    Pasquau-Liano, Juan
    PLOS ONE, 2016, 11 (02):
  • [4] Potential for simplification of HIV treatment with boosted protease inhibitor monotherapy
    Elena Reina
    Ramón San Miguel
    Natalia Larrea
    Patricia Garcia
    Victor Napal
    International Journal of Clinical Pharmacy, 2012, 34 : 911 - 916
  • [5] The Monark trial: where now for boosted protease inhibitor monotherapy?
    Hill, Andrew
    Hirschel, Bernard
    Katlama, Christine
    AIDS, 2008, 22 (06) : 777 - 779
  • [6] Boosted protease inhibitor monotherapy as a maintenance strategy: an observational study
    Guiguet, Marguerite
    Ghosn, Jade
    Duvivier, Claudine
    Meynard, Jean-Luc
    Gras, Guillaume
    Partisani, Marialuisa
    Teicher, Elina
    Mahamat, Aba
    Rodenbourg, Franck
    Launay, Odile
    Costagliola, Dominique
    AIDS, 2012, 26 (18) : 2345 - 2350
  • [7] Potential for simplification of HIV treatment with boosted protease inhibitor monotherapy
    Reina, Elena
    San Miguel, Ramon
    Larrea, Natalia
    Garcia, Patricia
    Napal, Victor
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2012, 34 (06) : 911 - 916
  • [8] Neurocognitive Performance in Ritonavir-boosted Protease Inhibitor Monotherapy
    Carvalhal, Adriana
    CLINICAL INFECTIOUS DISEASES, 2016, 63 (02) : 265 - 267
  • [9] Efficacy of boosted protease inhibitor monotherapy in patients with complex medical problems
    Garrett, Nigel J.
    Matin, Nasha
    Edwards, Simon G.
    Miller, Robert F.
    AIDS, 2007, 21 (13) : 1821 - 1823
  • [10] Outcomes of protease inhibitor Darunavir/Ritonavir (DRV/r) monotherapy in a clinical setting
    Castles, R.
    Pacho, C.
    Swan, J.
    Sonecha, S.
    Nelson, M.
    HIV MEDICINE, 2012, 13 : 70 - 70
12345